| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2063 |
| Trial ID | NCT03853616 |
| Disease | B-Cell Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM) |
| Year | 2018 |
| Country | Germany |
| Company sponsor | Miltenyi Biomedicine GmbH |
| Other ID(s) | M-2017-322|2017-002848-32 |
| Cohort 1 | |||||||||||||
|
|||||||||||||